These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 33096498

  • 1. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
    Sarfo FS, Ovbiagele B.
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
    [Abstract] [Full Text] [Related]

  • 2. Frequency and factors linked to refractory hypertension among stroke survivors in Ghana.
    Sarfo FS, Akassi J, Adamu S, Obese V, Agbenorku M, Ovbiagele B.
    J Neurol Sci; 2020 Aug 15; 415():116976. PubMed ID: 32535251
    [Abstract] [Full Text] [Related]

  • 3. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS, Akassi J, Agyei M, Kontoh S, Ovbiagele B.
    J Stroke Cerebrovasc Dis; 2020 Dec 15; 29(12):105304. PubMed ID: 32992189
    [Abstract] [Full Text] [Related]

  • 4. Apparent Treatment-Resistant Hypertension Among Stroke Survivors: A Transcontinental Study Assessing Impact of Race and Geography.
    Sarfo FS, Olasoji E, Banfill GP, Ovbiagele B, Simpkins AN.
    Am J Hypertens; 2022 Aug 01; 35(8):715-722. PubMed ID: 35366323
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study.
    Wu C, Wang Y, Zhang W, Li X, Wang L, Hui R.
    Clin Exp Hypertens; 2019 Aug 01; 41(8):753-758. PubMed ID: 30512984
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E, van der Sande NGC, Bots ML, Spiering W, Voskuil M, Visseren FLJ, Blankestijn PJ.
    BMJ Open; 2017 Sep 06; 7(9):e016692. PubMed ID: 28882918
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
    Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, Calhoun DA.
    Hypertension; 2013 Oct 06; 62(4):691-7. PubMed ID: 23918752
    [Abstract] [Full Text] [Related]

  • 8. Blood Pressure Control among Hypertensive Stroke Survivors in Nigeria.
    Wahab KW, Kolo PM, Salawu FK, Sanya EO.
    J Stroke Cerebrovasc Dis; 2017 Jun 06; 26(6):1222-1227. PubMed ID: 28189571
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson D, Noel Bairey Merz C, Pepine CJ, Cooper-Dehoff RM.
    J Am Heart Assoc; 2014 Feb 28; 3(1):e000660. PubMed ID: 24584740
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E, Bots ML, van Zuilen AD, Wetzels JF, Blankestijn PJ, MASTERPLAN Study Group.
    Hypertension; 2015 Nov 28; 66(5):998-1005. PubMed ID: 26351024
    [Abstract] [Full Text] [Related]

  • 11. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F, Piscitelli P, Ceriello A, Fioretto P, Giorda C, Guida P, Russo G, De Cosmo S, Pontremoli R, AMD‐Annals Study Group.
    J Am Heart Assoc; 2017 Sep 22; 6(9):. PubMed ID: 28939716
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP, Sakhuja S, Colvin CL, Clark D, Jaeger BC, Hardy ST, Howard G, Cohen LP, Irvin MR, Tanner R, Carey RM, Muntner P.
    Hypertension; 2020 Dec 22; 76(6):1953-1961. PubMed ID: 33131312
    [Abstract] [Full Text] [Related]

  • 13. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR, Booth JN, Shimbo D, Lackland DT, Oparil S, Howard G, Safford MM, Muntner P, Calhoun DA.
    J Am Soc Hypertens; 2014 Jun 22; 8(6):405-13. PubMed ID: 24952653
    [Abstract] [Full Text] [Related]

  • 14. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M, ALLHAT Collaborative Research Group.
    Hypertension; 2014 Nov 22; 64(5):1012-21. PubMed ID: 25259745
    [Abstract] [Full Text] [Related]

  • 15. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
    Bakris G, Lin PP, Xu C, Chen C, Ashton V, Singhal M.
    J Clin Hypertens (Greenwich); 2024 May 22; 26(5):500-513. PubMed ID: 38523465
    [Abstract] [Full Text] [Related]

  • 16. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
    Kaczmarski KR, Sozio SM, Chen J, Sang Y, Shafi T.
    BMC Nephrol; 2019 Apr 25; 20(1):138. PubMed ID: 31023262
    [Abstract] [Full Text] [Related]

  • 17. One-Year Rates and Determinants of Poststroke Systolic Blood Pressure Control among Ghanaians.
    Sarfo FS, Kyem G, Ovbiagele B, Akassi J, Sarfo-Kantanka O, Agyei M, Badu E, Adusei Mensah N.
    J Stroke Cerebrovasc Dis; 2017 Jan 25; 26(1):78-86. PubMed ID: 27639589
    [Abstract] [Full Text] [Related]

  • 18. Frequency & factors associated with apparent resistant hypertension among Ghanaians in a multicenter study.
    Ayisi-Boateng NK, Mohammed A, Opoku DA, Sarfo FS.
    J Clin Hypertens (Greenwich); 2020 Sep 25; 22(9):1594-1602. PubMed ID: 32815641
    [Abstract] [Full Text] [Related]

  • 19. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
    Petersen J, Malyutina S, Ryabikov A, Kontsevaya A, Kudryavtsev AV, Eggen AE, McKee M, Cook S, Hopstock LA, Schirmer H, Leon DA.
    BMC Cardiovasc Disord; 2020 Mar 13; 20(1):135. PubMed ID: 32169049
    [Abstract] [Full Text] [Related]

  • 20. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP, Jaeger BC, Safford MM, Oparil S, Carson AP, Sims A, Hannon L, Howard G, Muntner P, Hardy ST.
    J Am Heart Assoc; 2024 May 21; 13(10):e031695. PubMed ID: 38752519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.